This pilot study looked at 200 patients who had a heart attack and received a procedure called primary PCI. Researchers compared two treatments: ticagrelor alone versus a combination of ticagrelor and aspirin. The goal was to see if one method was safer or more effective over a 13-month period.
The results showed no significant difference between the two groups regarding major cardiac and cerebrovascular events. However, the group receiving ticagrelor alone showed a significant reduction in bleeding at the site where the procedure was performed. Other types of bleeding, such as internal bleeding in the heart muscle, were similar in both groups.
Because this was a small pilot study, the results are not enough to change standard medical practice. The study was not large enough to confirm if one treatment is definitely better than the other. Patients should talk to their doctors about which treatment plan is safest for their specific health needs.
Common questions
Is ticagrelor monotherapy safer than using both ticagrelor and aspirin?
The study found that ticagrelor alone significantly reduced bleeding at the procedure site compared to the dual-drug approach. However, there was no significant difference in the total number of major cardiac or cerebrovascular events between the two groups. Because this was a small pilot study, it cannot confirm which treatment is definitively safer.
What kind of bleeding was reduced in the study?
Patients taking ticagrelor alone showed a significant reduction in clinically relevant non-access site bleeding, which was 2.0% compared to 9.9% in the dual-drug group. Other types of bleeding, such as intramyocardial hemorrhage, were similar in both groups. You should discuss these specific risks with your doctor.
How many people were involved in this study?
The study included 200 patients who had a heart attack and underwent primary PCI. The researchers followed these patients for 13 months to track heart events and bleeding. Because the study was small, it is considered a pilot study and may not be enough to change standard medical practices.
